These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1032145)

  • 1. Effect of doxycycline administration on nitrogen excretion in bilharzial hepatic fibrosis and chronic renal failure cases.
    Hafiez AA; El-Kirdassy ZH; Abdel Khalik F; Hassaballa A; El-Ghonaimy E; Gaber A
    J Egypt Med Assoc; 1976; 59(3-4):273-86. PubMed ID: 1032145
    [No Abstract]   [Full Text] [Related]  

  • 2. Some aspects of iron metabolism in bilharzial liver cirrhosis.
    el-Shobaki FA; Morcos SR; el-Ahmady L; Ageeb M
    J Egypt Med Assoc; 1974; 57(1-2):49-56. PubMed ID: 4452752
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of glucose on hepatic conversion of aminonitrogen to urea in patients with cirrhosis: relationship to glucagon.
    Hamberg O; Vilstrup H
    Hepatology; 1994 Jan; 19(1):45-54. PubMed ID: 7903954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trace elements in bilharzial hepatic fibrosis and encephalopathy.
    Abdel-Maguid S; Maamoun MH; Abdel Wahab FM; Raafat S; Taha MA; Massoud MM; Makarem SS; Baddar MR
    J Egypt Soc Parasitol; 1986 Dec; 16(2):469-76. PubMed ID: 3782901
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum and ascitic fluid magnesium in bilharzial (schistosomal) hepatic fibrosis.
    Ghanem MH; Guirgis FK; el-Sawy M
    J Trop Med Hyg; 1970 Oct; 73(10):237-9. PubMed ID: 5478038
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatic amino-nitrogen clearance to urea-nitrogen in control subjects and in patients with cirrhosis: a simplified method.
    Bianchi G; Marchesini G; Vilstrup H; Fabbri A; De Mitri MS; Zoli M; Pisi E
    Hepatology; 1991 Mar; 13(3):460-6. PubMed ID: 1999317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unresponsiveness of hepatic nitrogen metabolism to glucagon infusion in patients with cirrhosis: dependence on liver cell failure.
    Fabbri A; Marchesini G; Bianchi G; Bugianesi E; Bortoluzzi L; Zoli M; Pisi E
    Hepatology; 1993 Jul; 18(1):28-35. PubMed ID: 8325618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The elimination of tritiated doxycycline in normal subjects and in patients with severely impaired renal function.
    Mahon WA; Johnson GE; Endrenyl L; Kelly MF; Fenton SS
    Scand J Infect Dis Suppl; 1976; (9):24-31. PubMed ID: 1070145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of systemic prostaglandin E1 on hepatic amino acid-nitrogen metabolism in patients with cirrhosis.
    Fabbri A; Bianchi G; Brizi M; Bugianesi E; Magalotti D; Zoli M; Marchesini G
    Hepatology; 1998 Mar; 27(3):815-21. PubMed ID: 9500712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What value keto acids or amino acids as dietary substitutes or supplements to low protein diets in adult chronic renal failure.
    Jackson MA
    Acta Chir Scand Suppl; 1981; 507():341-8. PubMed ID: 6797194
    [No Abstract]   [Full Text] [Related]  

  • 11. [Aspects of water-electrolyte metabolism studied with muscle needle-biopsy. Findings in cardiac insufficiency, hepatic cirrhosis, diabetes mellitus and chronic renal insufficiency].
    Ossi E; Mioni G; D'Angelo A; Lupo A; Valvo E; Maschio G
    G Clin Med; 1974 Feb; 55(2):131-44. PubMed ID: 4419276
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lower amines in the blood and urine in chronic liver and kidney diseases].
    Martin R; Pohl A; Rotzsch W
    Dtsch Z Verdau Stoffwechselkr; 1977; 37(2):85-8. PubMed ID: 608434
    [No Abstract]   [Full Text] [Related]  

  • 13. [The pharmacokinetics of doxycycline in kidney insufficiency in geriatric patients compared to younger adults].
    Simon C; Malerczyk V; Engelke H; Preuss I; Grahmann H; Schmidt K
    Schweiz Med Wochenschr; 1975 Nov; 105(48):1615-20. PubMed ID: 1215947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acid composition of serum lipids in bilharzial hepatic fibrosis and chronic active hepatitis.
    Gabr Y; Mahfouz M; Mohammed YS
    Acta Biol Med Ger; 1975; 34(1):45-51. PubMed ID: 1179920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potassium and nitrogen binding in the human gut by ingested oxidized starch (OS).
    Friedman EA; Fastook J; Beyer MM; Rattazzi T; Josephson AS
    Trans Am Soc Artif Intern Organs; 1974; 20A():161-7. PubMed ID: 4615421
    [No Abstract]   [Full Text] [Related]  

  • 16. [Several factors in the pathogenesis of hepatic failure in patients with liver cirrhosis and bleeding from esophageal and gastric varicose veins].
    Bour AV; Manuk'ian GV; Umruzakov IU; Shertsinger AG
    Anesteziol Reanimatol; 1993; (2):32-4. PubMed ID: 7943876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of doxycycline in human renal failure].
    Zech PY
    Nouv Presse Med; 1980 Jan; 9(21 Suppl):82-3. PubMed ID: 7355090
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum and urinary amino acid pattern in schistosomal infection among Egyptians.
    El-Shobaki FA; Shaker YM; El-Hawary MF; Saif M
    Tropenmed Parasitol; 1980 Mar; 31(1):94-8. PubMed ID: 7376258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophyrins in bilharzial hepatic fibrosis.
    Khattab M; El Mofty AM; Soliman L; Emara SH; Abdel Aal M
    J Trop Med Hyg; 1967 Nov; 70(11):259-64. PubMed ID: 6060255
    [No Abstract]   [Full Text] [Related]  

  • 20. Marked prolongation in disappearance half-time of plasma cholecystokinin-octapeptide in patients with hepatic cirrhosis.
    Kanayama S; Himeno S; Kurokawa M; Shinomura Y; Kuroshima T; Okuno M; Tsuji K; Higashimoto Y; Ikei N; Hashimura E
    Am J Gastroenterol; 1985 Jul; 80(7):557-60. PubMed ID: 4014106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.